A91 Partners is an India-focused venture capital firm that primarily invests patient capital in established, private, small to mid-sized companies at the early growth or late venture capital stage. Their investment strategy targets sectors such as consumer goods and services, healthcare, financial services, and technology.
They made 2 investments in the last 12 months. Average disclosed round size is $45.8M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
$1.5B
Top Stage
Series B
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| DDeccan AI | Series A | $25M | Mar 2026 |
 MoEngage | Series F | $100M | Nov 2025 |
 KaarTech | Series B | $30M | Jul 2023 |
 SUGAR Cosmetics | Series D | $50M | May 2022 |
 VideoVerse | Series B | $46.8M | Apr 2022 |
| PPublic App | Series C | $41M | Mar 2021 |
| AAye Finance | Series E | $27.5M | Jun 2020 |
Top Co-Investors
Falcon Edge1 shared
L Catterton1 shared
India Quotient1 shared
Goldman Sachs Alternatives1 shared
Alpha Wave Global1 shared
Innoven Capital1 shared
Pacific Western Bank1 shared
Susquehanna1 shared
Prosus Ventures1 shared
Last updated: 21 April 2026